Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Recent & Breaking News (TSX:OPS)

Opsens to Host Investor Webinar on Thursday, October 4 to Provide Update on Recent Developments

Canada NewsWire October 3, 2018

Opsens - New product for the diagnosis of coronary stenosis with the heart at rest

Canada NewsWire September 20, 2018

Opsens Reports Q3 2018 Results - Quarterly Revenues Eclipse $6.4 M

Canada NewsWire July 12, 2018

Opsens applauds Japanese government new regulation supporting diagnosis, such as FFR, before treatment of coronary stenosis

Canada NewsWire April 24, 2018

Opsens reports Q2 2018 results - Consolidated product sales up 44%

Canada NewsWire April 12, 2018

Opsens' technology granted FDA approval in Abiomed's Impella Cardiac Pump®

Canada NewsWire April 3, 2018

Opsens Reports Results of Shareholders Vote

Canada NewsWire January 31, 2018

Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville

Canada NewsWire January 23, 2018

Opsens Reports Q1 2018 Results - Record Quarterly Revenues With Growth in all Geographic Regions

Canada NewsWire January 15, 2018

Opsens' Japanese partner Zeon medical proceeds with Conversion of US$2 million Debenture

Canada NewsWire November 27, 2017

Opsens Reports 2017 Results - Consolidated Revenues Up 85% for Fiscal 2017

Canada NewsWire November 15, 2017

Opsens Gets Technological Award

Canada NewsWire October 24, 2017

Opsens Presents a Short Film at the International Medical Film Festival - Quebec in Good Health

Canada NewsWire September 13, 2017

Opsens Reports Q3 2017 Results - Another Record Quarter with Revenues Up 130% to $4.9 Million

Canada NewsWire June 29, 2017

Opsens - Robin Villeneuve Appointed as Chief Financial Officer

Canada NewsWire June 7, 2017

Opsens Inc. Presentation Now Available for On-Demand Viewing

PR Newswire May 16, 2017

Opsens to Webcast, Live, at Virtualinvestorconferences.com, May 11 at 1:30 pm ET

PR Newswire May 8, 2017

Opsens Announces departure of CFO

Canada NewsWire May 5, 2017

Opsens Announces Graduation to TSX

Canada NewsWire February 28, 2017

Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues

Canada NewsWire January 26, 2017